Mary Klotman, MD, talks with Dr. Michael Pencina, Professor of Biostatistics and Bioinformatics, Director of AI Health, and Duke Health’s first Chief Data Scientist about the enormous potential of Data Science and Artificial Intelligence have to improve health care, and also about how to avoid the potential pitfalls they present.

A Duke Health transplant patient decided to give back by joining OneDukeGen, the new precision medicine study that will analyze the DNA of 150,000 Duke patients and research study participants.

Once a rising star in Uruguayan field hockey, a Duke neuropsychologist now tackles disparities, aiming to reshape how the nation's largest, fastest-growing minority group receives Alzheimer’s and dementia care.

Fluvoxamine, an antidepressant, is one of four FDA-approved repurposed medications tested in ACTIV-6, a nationwide remote study.

Duke School of Medicine Symposium on Oct. 2-3 celebrates Robert Lefkowitz's 50- year career at Duke and honors his legacy of Nobel Prize-winning insights that transformed modern medicine.

Faculty members are exploring the use of ChatGPT in student learning environments, and their own personal research.

Physician Assistant (PA) Micaela Marker was looking for somewhere to donate her time when she saw an article in the Denver Post about a nonprofit organization called Global Care Force that was looking for volunteers for medical trips to Ukraine.

Mary Klotman, MD, talks with faculty member Leonor Corsino, MD, MHS, about improving health access and care in underrepresented populations.

A study in twins found that even a single traumatic brain injury at any age was associated with worse cognitive function in later life, independent of genes and environmental factors.

Co-authors Eric Elbogen, PhD, professor of psychiatry and behavioral sciences, and Nico Verykoukis, a retired clinical social worker with 29 years of experience, debunk the common myth that most perpetrators of violent crime are mentally ill.